Paper25246554
Alternating antibiotic treatments constrain evolutionary paths to multidrug resistance.
Kim S and 2 others. Proc Natl Acad Sci U S A, 2014. Cited by 195 papers, by iCite.
Cite this record
ConductScience Library. Alternating antibiotic treatments constrain evolutionary paths to multidrug resistance. Papers, record 25246554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25246554
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Drug Resistance, Multiple, Bacterial | Major topic |
| Staphylococcus aureus | Major topic |
| Drug Administration Schedule | |
| Drug Therapy | |
| Drug Therapy, Combination | |
| Evolution, Molecular | |
| Genome, Bacterial | |
| Humans | |
| Mutation | |
| Mutation Rate | |
| Staphylococcal Infections | |
| Time Factors |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 GM081617 | NIGMS NIH HHS | United States | R01GM081617 | PubMed and NIH |
| R01GM081617 | NIGMS NIH HHS | United States | R01GM081617 | PubMed and NIH |
Source NIH RePORTER
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 25402355 | Antimicrobials: The benefits of cycling. | https://conductscience.org/library/papers/25402355 |
Source PubMed
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9574680 | Detection of kanamycin-resistant Mycobacterium tuberculosis by identifying mutations in the 16S rRNA gene. | J Clin Microbiol | 1998 | https://conductscience.org/library/papers/9574680 | PubMed |
| 2 | 21378186 | Whole-genome sequencing of Staphylococcus aureus strain RN4220, a key laboratory strain used in virulence research, identifies mutations that affect not only virulence factors but also the fitness of the strain. | J Bacteriol | 2011 | https://conductscience.org/library/papers/21378186 | PubMed |
| 3 | 9514735 | Binding of neomycin-class aminoglycoside antibiotics to the A-site of 16 S rRNA. | J Mol Biol | 1998 | https://conductscience.org/library/papers/9514735 | PubMed |
| 4 | 15308772 | Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals. | Proc Natl Acad Sci U S A | 2004 | https://conductscience.org/library/papers/15308772 | PubMed |
| 6 | 10677558 | The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions. | Proc Natl Acad Sci U S A | 2000 | https://conductscience.org/library/papers/10677558 | PubMed |
| 7 | 19423463 | Trimethoprim-sulfamethoxazole for methicillin-resistant Staphylococcus aureus: a forgotten alternative? | J Chemother | 2009 | https://conductscience.org/library/papers/19423463 | PubMed |
| 8 | 21886955 | Tuberculosis chemotherapy in the 21 century: Back to the basics. | Lung India | 2011 | https://conductscience.org/library/papers/21886955 | PubMed |
| 9 | 21846669 | Breakthrough bacteraemia due to tigecycline-resistant Escherichia coli with New Delhi metallo-β-lactamase (NDM)-1 successfully treated with colistin in a patient with calciphylaxis. | J Antimicrob Chemother | 2011 | https://conductscience.org/library/papers/21846669 | PubMed |
| 10 | 2073096 | Ciprofloxacin-resistant methicillin-resistant Staphylococcus aureus in an acute-care hospital. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/2073096 | PubMed |
| 11 | 10075272 | Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary. | Int J Antimicrob Agents | 1999 | https://conductscience.org/library/papers/10075272 | PubMed |
| 12 | 19629166 | Positive epistasis drives the acquisition of multidrug resistance. | PLoS Genet | 2009 | https://conductscience.org/library/papers/19629166 | PubMed |
| 13 | 11856810 | Emergence of macrolide resistance during treatment of pneumococcal pneumonia. | N Engl J Med | 2002 | https://conductscience.org/library/papers/11856810 | PubMed |
| 14 | 22081229 | Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes. | Nat Genet | 2011 | https://conductscience.org/library/papers/22081229 | PubMed |
| 15 | 21175677 | Antibiotic heterogeneity: from concept to practice. | Ann N Y Acad Sci | 2010 | https://conductscience.org/library/papers/21175677 | PubMed |
| 16 | 10217777 | The Staphylococcus aureus rsbW (orf159) gene encodes an anti-sigma factor of SigB. | J Bacteriol | 1999 | https://conductscience.org/library/papers/10217777 | PubMed |
| 17 | 7726483 | Trimethoprim and sulfonamide resistance. | Antimicrob Agents Chemother | 1995 | https://conductscience.org/library/papers/7726483 | PubMed |
| 18 | 15577930 | Antibacterial resistance worldwide: causes, challenges and responses. | Nat Med | 2004 | https://conductscience.org/library/papers/15577930 | PubMed |
| 19 | 15942878 | Mechanisms of resistance to quinolones. | Clin Infect Dis | 2005 | https://conductscience.org/library/papers/15942878 | PubMed |
| 20 | 21077716 | Antibiotic cycling versus mixing: the difficulty of using mathematical models to definitively quantify their relative merits. | Math Biosci Eng | 2010 | https://conductscience.org/library/papers/21077716 | PubMed |
| 21 | 11155849 | Antibiotic synergy and antagonism. | Med Clin North Am | 2000 | https://conductscience.org/library/papers/11155849 | PubMed |
Cited by152
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 195 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42747582 | Collateral sensitivity-harnessing microbial vulnerabilities as a solution to antimicrobial resistance. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42747582 | PubMed |
| 42655135 | Impaired Membrane Energetics Underlies Collateral Sensitivity to Amphenicols During Meropenem Resistance Evolution in Escherichia coli. | Microorganisms | 2026 | https://conductscience.org/library/papers/42655135 | PubMed |
| 42409578 | High-accuracy SNV calling for bacterial isolates using deep learning with AccuSNV. | Genome Res | 2026 | https://conductscience.org/library/papers/42409578 | PubMed |
| 42244761 | Minimal Computational Framework for Systematic Identification of Antimicrobial Targets. | bioRxiv | 2026 | https://conductscience.org/library/papers/42244761 | PubMed |
| 42043193 | Sequential Phage Delivery Can Outperform Cocktails by Delaying Cross-Resistance Evolution. | Viruses | 2026 | https://conductscience.org/library/papers/42043193 | PubMed |
| 41637025 | Repurposed bunamidine disrupts envelope energetics and induces ROS-mediated non-lytic killing. | AMB Express | 2026 | https://conductscience.org/library/papers/41637025 | PubMed |
| 41284101 | Advanced integrated Eco-strategies for effective antibiotic waste management. | Biodegradation | 2025 | https://conductscience.org/library/papers/41284101 | PubMed |
| 41256411 | High-accuracy SNV calling for bacterial isolates using deep learning with AccuSNV. | bioRxiv | 2025 | https://conductscience.org/library/papers/41256411 | PubMed |
| 41036854 | Characterizing Staphylococcus aureus genomic epidemiology with multilevel genome typing. | mSystems | 2025 | https://conductscience.org/library/papers/41036854 | PubMed |
| 40846761 | Evolutionary drivers of divergent collateral sensitivity responses during antibiotic therapy. | Nat Ecol Evol | 2026 | https://conductscience.org/library/papers/40846761 | PubMed |
| 40535478 | Distinct ARG profiles associated with class 1 integrons in municipal and industrial wastewater treatment plants. | Environ Sci Ecotechnol | 2025 | https://conductscience.org/library/papers/40535478 | PubMed |
| 40498821 | Fitness seascapes are necessary for realistic modeling of the evolutionary response to drug therapy. | Sci Adv | 2025 | https://conductscience.org/library/papers/40498821 | PubMed |
| 40478208 | Tripartite Loops Reverse Antibiotic Resistance. | Mol Biol Evol | 2025 | https://conductscience.org/library/papers/40478208 | PubMed |
| 40204696 | Ceftazidime-avibactam use selects multidrug-resistance and prevents designing collateral sensitivity-based therapies against Pseudomonas aeruginosa. | Nat Commun | 2025 | https://conductscience.org/library/papers/40204696 | PubMed |
| 39902939 | Exploring the effect of sequential antibiotic exposure in resistant Escherichia coli causing urinary tract infections: a proof of principle study. | Microbiol Spectr | 2025 | https://conductscience.org/library/papers/39902939 | PubMed |
| 39843924 | Drug combinations targeting antibiotic resistance. | NPJ Antimicrob Resist | 2024 | https://conductscience.org/library/papers/39843924 | PubMed |
| 39623067 | Systematic mapping of antibiotic cross-resistance and collateral sensitivity with chemical genetics. | Nat Microbiol | 2025 | https://conductscience.org/library/papers/39623067 | PubMed |
| 39472696 | Collateral sensitivity counteracts the evolution of antifungal drug resistance in Candida auris. | Nat Microbiol | 2024 | https://conductscience.org/library/papers/39472696 | PubMed |
| 39339174 | Drug-Drug Interactions in Nosocomial Infections: An Updated Review for Clinicians. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/39339174 | PubMed |
| 39203492 | "Stop, Little Pot" as the Motto of Suppressive Management of Various Microbial Consortia. | Microorganisms | 2024 | https://conductscience.org/library/papers/39203492 | PubMed |
Data2
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession | Source |
|---|---|---|
| BioProject | PRJNA257510 | BioProject |
| SRA | SRP045373 | SRA |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Genes
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25246554
GET https://conductscience.org/api/papers/v1/25246554/references?page=2